Postdoc: Tumor Microenvironment & Lymph Node Reprogramming

Gruppo San Donato; Milano; In loco; EUR 27.900 - 39.060; Tempo pieno

Descrizione del lavoro

San Raffaele Scientific Institute in Milan invites applications for a junior postdoctoral fellow to join the Lymphoid Stromal Cell Biology Unit of the Comprehensive Cancer Center. The project investigates reprogramming of the tumor draining lymph node in melanoma, focusing on transcriptional and phenotypic changes in stromal and immune cells.

The candidate will use cutting-edge 3D culture, single-cell RNA sequencing, and spectral flow cytometry, with access to preclinical cancer models.

Competenze

• Ph.D. in cancer biology, immunology, or equivalent research experience.
• Hands-on experience in flow cytometry, confocal imaging and pre-clinical models of cancer.
• Ability to teamwork, a solution-oriented attitude, and excellent organization skills.
• Excellent communication skills in spoken and written English are expected.

Mansioni

• Investigate transcriptional and phenotypic reprogramming of stromal and immune cells in tumor-draining lymph nodes (TDLNs).
• Utilize advanced 3D dynamic culture systems, single-cell RNA sequencing, and spectral flow cytometry.
• Collaborate with a multidisciplinary team and communicate findings effectively in English.

Conoscenze

Flow cytometry

Confocal imaging

Teamwork

Organization

English communication

Pre-clinical cancer models

Formazione

Ph.D. in cancer biology or immunology

Strumenti

3D dynamic culture systems

Single-cell RNA sequencing

Spectral flow cytometry

Preclinical cancer models

Descrizione del lavoro

San Raffaele Scientific Institute in Milan invites applications for a junior postdoctoral fellow to join the Lymphoid Stromal Cell Biology Unit of the Comprehensive Cancer Center. The project investigates reprogramming of the tumor draining lymph node in melanoma, focusing on transcriptional and phenotypic changes in stromal and immune cells.

The candidate will use cutting-edge 3D culture, single-cell RNA sequencing, and spectral flow cytometry, with access to preclinical cancer models.